BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30310507)

  • 1. A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio.
    Song Y; Chen Z; Chen L; He C; Huang X; Duan F; Wang J; Lao X; Li S
    J Cancer; 2018; 9(19):3507-3514. PubMed ID: 30310507
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
    Jiang Y; Su Y; Chen Y; Li Z
    J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
    [No Abstract]   [Full Text] [Related]  

  • 4. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
    Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
    Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System.
    Ren H; Wu CR; Qiu GT; Zhang LP; Aimaiti S; Wang CF
    J Oncol; 2020; 2020():9093729. PubMed ID: 33014058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of American Joint Committee on Cancer 8
    Yin F; Saad M; Xie H; Lin J; Jackson CR; Ren B; Lawson C; Karamchandani DM; Bernabeu BQ; Jiang W; Dhir T; Zheng R; Schultz CW; Zhang D; Thomas CL; Zhang X; Lai J; Schild M; Zhang X; Liu X
    World J Gastrointest Pharmacol Ther; 2020 Jun; 11(2):25-39. PubMed ID: 32550043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three lymph node staging schemes for predicting the outcome in patients with small bowel adenocarcinoma: A population-based cohort and international multicentre cohort study.
    Zhou YY; Du XJ; Zhang CH; Aparicio T; Zaanan A; Afchain P; Chen LP; Hu SK; Zhang PC; Wu M; Zhang QW; Wang H
    EBioMedicine; 2019 Mar; 41():276-285. PubMed ID: 30824384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.
    Kutlu OC; Watchell M; Dissanaike S
    Surg Oncol; 2015 Jun; 24(2):84-8. PubMed ID: 25912951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model.
    Bertsimas D; Margonis GA; Huang Y; Andreatos N; Wiberg H; Ma Y; Mcintyre C; Pulvirenti A; Wagner D; van Dam JL; Gavazzi F; Buettner S; Imai K; Stasinos G; He J; Kamphues C; Beyer K; Seeliger H; Weiss MJ; Kreis M; Cameron JL; Wei AC; Kornprat P; Baba H; Koerkamp BG; Zerbi A; D'Angelica M; Wolfgang CL
    JCO Clin Cancer Inform; 2021 Dec; 5():1220-1231. PubMed ID: 34936469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
    La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
    Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
    Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
    Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
    Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
    Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
    Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM
    J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
    Meng Z; Cao M; Zhang Y; Liu Z; Wu S; Wu H
    BMC Gastroenterol; 2019 Apr; 19(1):59. PubMed ID: 31014264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.
    Liu ZQ; Xiao ZW; Luo GP; Liu L; Liu C; Xu J; Long J; Ni QX; Yu XJ
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):634-41. PubMed ID: 25475867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.